Company Profile

Olink Stock Price, News & Analysis

Ticker:
OLK
Exchange:
NASDAQ
Sector:
Biotechnology
Location:
United States

Stock performance

26.08 USD

Close

Last updated: July 9, 2024 at 00:00

Market cap

Why the stock is moving

OLK is trading with a steady catalyst profile while investors wait for the next headline that changes the story.

Company overview

Business overview

Olink is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

Geographic Base and Sector Classification

Headquartered in the United States and listed on NASDAQ, Olink is followed within the biotech universe for its exposure to catalyst-driven execution.

Business Model Characteristics

Olink follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.

Position Within the Biotechnology Landscape

Compared with more mature healthcare peers, Olink sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.

Future catalysts

Recent news

The five most recent related feed items are shown below in reverse chronological order.

  1. 01

    Zimmer Biomet Names Chintan Desai President of Asia Pacific Region

    ZBH · Source: Zimmer Biomet

  2. 02
  3. 03
  4. 04
  5. 05

Similar stocks

Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.

Frequently Asked Questions

What is the current stock price of Olink (OLK)?

Olink (OLK) most recently closed at 26.08 USD.

What does Olink do?

Olink is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

On which exchange is OLK stock listed?

Olink (OLK) is associated with NASDAQ, United States, Biotechnology.

What is Olink?

Olink is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.

Which conditions is Olink targeting with Olink?

Olink is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

What is Investors?

Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.